Primary Hypereosinophilic Syndrome and Stroke: Mechanisms and Diagnosis in Ready-made Diagnoses
Melike Çakan
◽
Mehmet Akif Topçuoğlu
G Yavuz
◽
T Kauke
◽
OM Glück
◽
T Weig
◽
K Milger-Kneidinger
◽
...
2007 ◽
Vol 179
(4)
◽
pp. 341-343
M. Horger
◽
W. Schöber
◽
J. Joanoviciu
◽
H. Brodöfel
1993 ◽
Vol 29
(4)
◽
pp. 757
Gi Beom Kim
◽
Ok Hwoa Kim
◽
Jong Min Lee
◽
Yeong Soon Sung
◽
Duk Sik Kang
1997 ◽
Vol 37
(4)
◽
pp. 673
◽
Kyung Sook Kim
◽
Moon Gyu Lee
◽
Young Chul Won
◽
Eun Hye Lee
◽
Han Na Noh
◽
...
1991 ◽
Vol 53
(3)
◽
pp. 525-529
◽
Kenichi MORI
◽
Mamoru KOHDA
◽
Yasuji MORI
◽
Hiroaki UEKI
◽
Masahiko KUMAGAI
1998 ◽
Vol 60
(2)
◽
pp. 134-136
◽
Yuka TAKAMATSU
◽
Tomomi SODO
◽
Fumiaki SHIRASAKI
◽
Hideaki SAKAI
◽
Kazuhiko TAKEHARA
◽
...
Human medicines European public assessment report (EPAR): Glivec, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Gastrointestinal Stromal Tumors,Dermatofibrosarcoma,Myelodysplastic-Myeloproliferative Diseases,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Hypereosinophilic Syndrome, Date of authorisation: 07/11/2001, Revision: 35, Status: Authorised